Detail of "14649-03-7"

MSDS Download
CAS Number:
14649-03-7
Name:
Benzene,[(1S)-1-isocyanatoethyl]-
Superlist Name:
(S)-(-)-1-Phenylethyl isocyanate
Molecular Structure:
Formula:
C₉H₉NO
Molecular Weight:
147.17
Synonyms:
Benzene,(1-isocyanatoethyl)-, (S)-;Isocyanic acid, a-methylbenzyl ester, (-)- (8CI);((1S)-1-Isocyanatoethyl)benzene;(-)-(S)-a-Methylbenzyl isocyanate;(-)-(S)-a-Phenethyl isocyanate;(-)-(S)-a-Phenylethyl isocyanate;(-)-1-Phenethyl isocyanate;(-)-1-Phenylethyl isocyanate;(-)-a-Methylbenzyl isocyanate;(-)-a-Phenylethyl isocyanate;(S)-(-)-a-Methylbenzyl isocyanate;(S)-1-Phenethyl isocyanate;(S)-1-Phenyl-1-isocyanatoethane;(S)-1-Phenylethylisocyanate;(S)-a-Methylbenzylisocyanate;S-(-)-a-Phenylethyl isocyanate;[(S)-1-Isocyanatoethyl]benzene;
EINECS:
238-698-6
Density:
0.982 g/cm³
Boiling Point:
204.089 °C at 760 mmHg
Flash Point:
65.556 °C
Solubility:
decomposes in water
Appearance:
Colorless to light yellow liquid
Hazard Symbols:
Xn; T+
Risk Codes:
36/37/38-42-26
Safety:
23-26-36-45-24/25 Details
Transport Information:
UN 2206

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Preparation of butenolide endothelin antagonists: Preparation of butenolide endothelin antagonists. Patt, William Chester; Reisdorp, Bill R.; Repine, Joseph Thomas ( Warner-Lambert Company; Patt, William Chester; Reisdorp, Bill R.; Repine, Joseph Thomas, USA). PCT Int. 14649-03-7 and 187533-60-4 are also occured in this study. Appl. WO 9702265 A1 23 Jan 1997, 50 pp. DESIGNATED STATES: W: AU, BG, CA, CN, CZ, EE, GE, HU, IL, JP, KR, LT, LV, MX, NO, NZ, PL, RO, SG, SI, SK, UA, US, UZ, AM, AZ, BY, KG, KZ, MD, RU, TJ, TM; RW: AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE. (English). (World Intellectual Property Organization). CODEN: PIXXD2. CLASS: ICM: C07D407-04. ICS: C07D307-60; A61K031-365. APPLICATION: WO 1996-US10651 21 Jun 1996. PRIORITY: US 1995-904 6 Jul 1995. DOCUMENT TYPE: Patent CA Section: 27 (Heterocyclic Compounds (One Hetero Atom)) Section cross-reference(s): 1 Title compds. [I; R = CONHR4; R1 = cycloalkyl, Ph, heteroaryl, etc.; R2,R3 = (cyclo)alkyl, (hetero)aryl, etc.; R4 = alkyl, (hetero)aryl, etc.] were prepd. Thus, I [R1 = benzo[1,3]dioxol-5-yl, R2 = CH2Ph, R3 = C6H4(OMe)-4](II; R = H) was condensed with (S)-PhCHMeNCO to give II [R = (S)-CONHCHMePh]. Data for biol. activity of I were given. .

Preparation of eseroline and 7-bromoseroline: Preparation of eseroline and 7-bromoseroline. Gektidis, Simeon; Brill, Hannelore (Gektidis, Simeon; Brill, Hannelore, Germany). Ger. Offen. DE 19525272 A1 16 Jan 1997, 6 pp. (German). (Germany). CODEN: GWXXBX. CLASS: ICM: C07D487-04. APPLICATION: DE 1995-19525272 13 Jul 1995. DOCUMENT TYPE: Patent CA Section: 31 (Alkaloids) (±)-Eseroline, (±)-7-bromoseroline, and optically active 5-hydroxy-1,3a,8-trimethyl-3,3a,8,8a-tetrahydropyrrolo[2,3-b]indol-2-on e were prepd. Thus, (±)-I (X = O) was reduced with LiAlH4 to give 92% (±)-eseroline (I, X = H2). 187024-09-5 and 14649-03-7 are just another two chemicals used in this study. .